Metabolism - Clinical and Experimental
Volume 46, Issue 2 , Pages 135-139, February 1997

Clofibrate feeding to Sprague-Dawley rats increases endogenous biosynthesis of oxalate and causes hyperoxaluria☆☆

  • Vimal Sharma

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Vimal Sharma, PhD, Associate Professor, Agriculture Research Station, Sanchar Kendra, University Campus, Udaipur, 313 001, India.
  • ,
  • Paul Otto Schwille

Division of Experimental Surgery and Endocrine Research Laboratory, Department of Surgery, University of Erlangen, Erlangen, Germany

Received 30 October 1995; accepted 3 September 1996.

Abstract 

The effects of clofibrate feeding (5 g/kg diet) on oxalate metabolism were investigated in male and female rats. Following clofibrate feeding, 24-hour urinary excretion of oxalate increased until 4 days and then reached a plateau. Whereas the contribution of dietary oxalate (1.4 g/kg diet, as potassium salt) to urinary oxalate was less than 5% in both control and clofibrate-treated male rats, the contribution of dietary glycolate (1.0 g/kg diet, as sodium salt) to urinary oxalate was six times higher in clofibrate-treated male rats compared with controls, indicating that the clofibrate-induced hyperoxaluria is due to increased endogenous biosynthesis of oxalate. This was supported by the increased lactate dehydrogenase (LDH) activity observed in liver supernatants of clofibrate-treated rats compared with controls, and the increased rate of conversion of glycolate and glyoxylate to oxalate by clofibrate-treated male rat liver supernatants. Female rats had lower excretion of urinary oxalate and lower levels of liver glycolic acid oxidase (GAO) as compared with males. Clofibrate-treated female rat liver supernatants had higher LDH levels and produced more oxalate from glyoxylate. Thus, it can be concluded that the increase in LDH activity may be the cause of the increased endogenous biosynthesis of oxalate leading to increased urinary excretion of oxalate in male and female rats treated with clofibrate.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by Deutsche Forschungsgemeinschaft, Bonn, Germany, and University of Erlangen Hospital research funds.

☆☆ Presented in part at Societe Francaise de Biochemie et de Biologie Moleculaire/Societe de Biologie Cellulaire de France International Meeting on Cellular Aspects Related to Peroxisomes, April 28–29, 1993, Dijon, France.

PII: S0026-0495(97)90290-0

Metabolism - Clinical and Experimental
Volume 46, Issue 2 , Pages 135-139, February 1997